RecallDepth
Class II Ongoing

Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
February 5, 2024
Posted
March 6, 2024
Recall Number
D-0350-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
54,960 bottles
Firm Location
Princeton, NJ, United States

Reason for Recall

Failed Dissolution Specifications: Out of specification for dissolution.

Distribution

Nationwide in the U.S.

Lot / Code Info

Lot #s: MHD0606A, MHD0612A, Exp. 04/30/2024; MHD0613A, MHD0652A, MHD0657A, MHD0672A, MHD0673A, Exp. 05/31/2024; MHD0767A, MHD0768A, MHD0769A, MHD0785A, MHD0799A, MHD0800A, MHD0801A, Exp. 06/30/2024; MHD0827A, MHD0828A, MHD0875A, MHD0876A, MHD0898A, MHD0901A, Exp. 07/31/2024; MHD1081A, MHD1082A, MHD1087A Exp. 09/30/2024.

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls